Sun, Dec 21, 2014, 5:05 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Pacira Pharmaceuticals, Inc. Message Board

  • biotracker76 biotracker76 Aug 2, 2013 9:05 PM Flag

    DRRX Conference Call

    PCRX shareholders should listen in to the DRRX call on Monday for an update on Posidur. Posidur is a clear "Exparel-Killer"; it's a vastly superior product with 72 hours of true pain relief under pain at movement vs. Exparel's 24 hours of pain relief at rest. PDUFA date is 2/14/14 so if FDA approves Posidur, expect PCRX to be a

94.47+0.53(+0.56%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.